AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

Facebook's Charts Are Sagging and May Need a Facelift

Let's review the charts and indicators.

Investors Should Continue to Feel the Warmth of SunPower

SPWR could continue to power higher in the long-term.

Let's Look to TLT to Chart the Future of Interest Rates

This is the direction the yield on the 10-year treasury looks to be headed.

Bluebird Bio Is Not Ready to Fly

BLUE needs a bigger base to launch a sustained uptrend.

Emergent BioSolutions Is Looking Stronger

Here's an update on EBS shares.

Bristol-Myers Squibb Could Finally Make Its Move

Traders should stay long and consider increasing their exposure.

Medtronic Points Up, but Wait for More Strength to Buy

The technical indicators are mixed for the big medical device maker and suggest bulls are not strongly behind the latest advance in the shares.

Danaher Could Trade Higher

I do not find enough technical reasons to recommend new long positions at this point in time.

GrowGeneration Could Pull Back - Time to Take Some Profits

GRWG shows a bearish divergence between price and the OBV line.

Here's Why Eli Lilly Broke to the Upside

Let's review the charts and indicators.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight